375 related articles for article (PubMed ID: 16143583)
1. C-reactive protein in patients with COPD, control smokers and non-smokers.
Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR
Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583
[TBL] [Abstract][Full Text] [Related]
2. [C-Reactive protein levels in patients with chronic obstructive pulmonary disease].
Díaz O; Parada A; Ramos C; Klaassen J; Díaz JC; Andresen M; Lisboa C; Saldías F
Rev Med Chil; 2012 May; 140(5):569-78. PubMed ID: 23096661
[TBL] [Abstract][Full Text] [Related]
3. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
4. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
6. Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease.
Biljak VR; Rumora L; Cepelak I; Pancirov D; Popović-Grle S; Sorić J; Stjepanović G; Grubisić TZ
Coll Antropol; 2013 Mar; 37(1):221-7. PubMed ID: 23697277
[TBL] [Abstract][Full Text] [Related]
7. Sex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin-1 gene polymorphism. A case-control study.
Kaparianos A; Argyropoulou E; Efremidis G; Spiropoulos K
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1149-57. PubMed ID: 22165675
[TBL] [Abstract][Full Text] [Related]
8. Associations between BODE index and systemic inflammatory biomarkers in COPD.
Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease.
Fimognari FL; Loffredo L; Di Simone S; Sampietro F; Pastorelli R; Monaldo M; Violi F; D'Angelo A
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):654-9. PubMed ID: 19282159
[TBL] [Abstract][Full Text] [Related]
10. High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD.
Liu SF; Wang CC; Chin CH; Chen YC; Lin MC
Arch Bronconeumol; 2011 Sep; 47(9):427-32. PubMed ID: 21821335
[TBL] [Abstract][Full Text] [Related]
11. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
Zhang L; Cheng Z; Liu W; Wu K
COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
[TBL] [Abstract][Full Text] [Related]
13. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
Wu SJ; Chen P; Jiang XN; Liu ZJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease.
van Durme YM; Verhamme KM; Aarnoudse AJ; Van Pottelberge GR; Hofman A; Witteman JC; Joos GF; Brusselle GG; Stricker BH
Am J Respir Crit Care Med; 2009 Mar; 179(5):375-82. PubMed ID: 19096002
[TBL] [Abstract][Full Text] [Related]
15. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
16. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.
Thomsen M; Dahl M; Lange P; Vestbo J; Nordestgaard BG
Am J Respir Crit Care Med; 2012 Nov; 186(10):982-8. PubMed ID: 22983959
[TBL] [Abstract][Full Text] [Related]
18. Relation between physical capacity, nutritional status and systemic inflammation in COPD.
Hallin R; Janson C; Arnardottir RH; Olsson R; Emtner M; Branth S; Boman G; Slinde F
Clin Respir J; 2011 Jul; 5(3):136-42. PubMed ID: 21679348
[TBL] [Abstract][Full Text] [Related]
19. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients.
de Torres JP; Cordoba-Lanus E; López-Aguilar C; Muros de Fuentes M; Montejo de Garcini A; Aguirre-Jaime A; Celli BR; Casanova C
Eur Respir J; 2006 May; 27(5):902-7. PubMed ID: 16455829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
